Mar. 26 2024
Source Page: Whole of Government Accounts, 2021-22Found: Business Interruption Loan Scheme (CBILS)/Coronavirus Large Businesses Interruption Loan Scheme (CLBILS
Mar. 14 2024
Source Page: Government Counter Fraud Functional Strategy 2024-2027Found: corruption Preventing fraud through effective counter fraud practices reduces loss and reputational damage
Mar. 14 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023Found: Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer- BioNTech Coronavirus
Mar. 14 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 27 November 2023Found: If yes, please specify the nature of the funding (donation, payment for services etc).4.
Found: to the coronavirus Covid-19 pandemic.
Found: Expenditure incurred in relation to the Covid-19 Vaccine Taskforce.Payments for services incurred by
Oral Evidence Feb. 28 2024
Inquiry: Emerging diseases and learnings from covid-19Found: so I assume that you cannot simply keep people on permanently without a contract—in other words, payment
Feb. 27 2024
Source Page: Supplementary Estimates 2023-24Found: Expenditure incurred in relation to the Covid-19 Vaccine Taskforce.
Feb. 27 2024
Source Page: Supplementary Estimates 2023-24Found: The Guarantee would not guarantee payment to the NAAFI Pension Scheme of NAAFI's obligations, as that
Asked by: Alexander Stafford (Conservative - Rother Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what proportion of (a) compensation and (b) successful applications of awards given out by the vaccine damage payment scheme related to a covid-19 vaccinations since the addition of the covid-19 vaccines to the vaccine damage payment scheme.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Between COVID-19 being added to the Vaccine Damage Payment Scheme (VDPS) on 31 December 2020 and 5 February 2024, 163 claims have received an award that relates to COVID-19. This constitutes 98% of awarded VDPS claims in this period, with four claims receiving an award that relates to other diseases.
It is important to note that the VDPS is not a compensation scheme. £19,560,000 has been awarded for claims relating to COVID-19, including pending payments. This constitutes 98% of VDPS awards in this period, with £480,000 having been paid to awarded claims relating to other diseases.